Form 4: Bio-Key International Director Acquires Shares in Lieu of Board Fees

Emmanuel Alia, a director at Bio-Key International, acquired 2,971 shares of common stock on March 20, 2025, as payment for board meeting attendance fees.

Summary

• On March 20, 2025, Emmanuel Alia, a director of Bio-Key International, acquired 2,971 shares of common stock.
• The acquisition was made under the Issuer's 2023 Stock Incentive Plan.
• The shares were issued in payment of board meeting attendance fees.
• Following the transaction, Alia directly owns 12,426 shares of Bio-Key International.
• The transaction was reported on March 21, 2025.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing. It doesn't inherently indicate positive or negative sentiment, but rather reports a transaction.

Positives

• A director is increasing their stake in the company, which could be seen as a positive signal.

Industry Context

This is a routine disclosure related to insider transactions and is common for publicly traded companies.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment as it shows a director increasing their investment in the company.

Key Dates

Keywords

Form 4, Beneficial Ownership, Director, BKYI, Bio-Key International, Stock Incentive Plan, Emmanuel Alia, Shares